BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarocchi M, Polvani S, Marroncini G, Galli A. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 2014; 20(33): 11630-11640 [PMID: 25206269 DOI: 10.3748/wjg.v20.i33.11630] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 100] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Stella L, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World J Gastroenterol 2022; 28(21): 2251-2281 [DOI: 10.3748/wjg.v28.i21.2251] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Panasiuk YV, Vlasenko NV, Churilova NS, Klushkina VV, Dubodelov DV, Kudryavtseva EN, Korabelnikova MI, Rodionova ZS, Semenenko TA, Kuzin SN, Akimkin VG. [Modern views on the role of X gene of the hepatitis B virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus) in the pathogenesis of the infection it causes]. Vopr Virusol 2022;67:7-17. [PMID: 35293184 DOI: 10.36233/0507-4088-84] [Reference Citation Analysis]
3 Li J, Chen Y, Guo X, Bai X, Xu X, Han T, Tan A, Liu N, Xia Y, Sun Q, Guo X, Chen J, Kang J. lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells. Mol Ther Nucleic Acids 2022;27:1064-77. [PMID: 35228900 DOI: 10.1016/j.omtn.2022.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shaikh IA, Muddapur UM, C K, Badiger S, Kulkarni M, Mahnashi MH, Alshamrani SA, Huneif MA, More SS, Khan AA, Iqubal SMS. In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV. Molecules 2022;27:1513. [PMID: 35268612 DOI: 10.3390/molecules27051513] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Letafati A, Najafi S, Mottahedi M, Karimzadeh M, Shahini A, Garousi S, Abbasi-Kolli M, Sadri Nahand J, Tamehri Zadeh SS, Hamblin MR, Rahimian N, Taghizadieh M, Mirzaei H. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cell Mol Biol Lett 2022;27:14. [PMID: 35164678 DOI: 10.1186/s11658-022-00317-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
6 Bousali M, Karamitros T. Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma. Microorganisms 2022;10:253. [DOI: 10.3390/microorganisms10020253] [Reference Citation Analysis]
7 Russo FP, Zanetto A, Pinto E, Battistella S, Penzo B, Burra P, Farinati F. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand? Int J Mol Sci 2022;23:500. [PMID: 35008926 DOI: 10.3390/ijms23010500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Lefeuvre C, Le Guillou-Guillemette H, Ducancelle A. A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis. Int J Mol Sci 2021;22:13651. [PMID: 34948447 DOI: 10.3390/ijms222413651] [Reference Citation Analysis]
9 Wong LM, Li WT, Shende N, Tsai JC, Ma J, Chakladar J, Gnanasekar A, Qu Y, Dereschuk K, Wang-Rodriguez J, Ongkeko WM. Analysis of the immune landscape in virus-induced cancers using a novel integrative mechanism discovery approach. Comput Struct Biotechnol J 2021;19:6240-54. [PMID: 34900135 DOI: 10.1016/j.csbj.2021.11.013] [Reference Citation Analysis]
10 Klöhn M, Schrader JA, Brüggemann Y, Todt D, Steinmann E. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5867. [PMID: 34831021 DOI: 10.3390/cancers13225867] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Qu MM, Zhu YH, Li YX, Li ZF, Li JK, Xu YS, Shrestha M, Lei JQ. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature. Medicine (Baltimore) 2021;100:e27349. [PMID: 34797273 DOI: 10.1097/MD.0000000000027349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Malik S, Prasad S, Kishore S, Kumar A, Upadhyay V. A perspective review on impact and molecular mechanism of environmental carcinogens on human health. Biotechnol Genet Eng Rev 2021;37:178-207. [PMID: 34672914 DOI: 10.1080/02648725.2021.1991715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Deng X, Cheng J, Zhan N, Chen J, Zhan Y, Ni Y, Liao C. MicroRNA-135a expression is upregulated in hepatocellular carcinoma and targets long non-coding RNA TONSL-AS1 to suppress cell proliferation. Oncol Lett 2021;22:808. [PMID: 34630715 DOI: 10.3892/ol.2021.13069] [Reference Citation Analysis]
14 Fulcher IR, Shpitser I, Didelez V, Zhou K, Scharfstein DO. Discussion on "Causal mediation of semicompeting risks" by Yen-Tsung Huang. Biometrics 2021. [PMID: 34510405 DOI: 10.1111/biom.13519] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Bousali M, Papatheodoridis G, Paraskevis D, Karamitros T. Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. Microorganisms 2021;9:1787. [PMID: 34442866 DOI: 10.3390/microorganisms9081787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang C, Xiao C, Ren G, Cai D, Long L, Li J, Li K, Tang Y, Huang T, Deng W. C-terminal-truncated hepatitis B virus X protein promotes hepatocarcinogenesis by activating the MAPK pathway. Microb Pathog 2021;159:105136. [PMID: 34390769 DOI: 10.1016/j.micpath.2021.105136] [Reference Citation Analysis]
17 Han J, Thurnherr T, Chung AYF, Goh BKP, Chow PKH, Chan CY, Cheow PC, Lee SY, Lim TKH, Chong SS, Ooi LLPJ, Lee CG. Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:2772. [PMID: 34199580 DOI: 10.3390/cancers13112772] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Chen YS, Hsieh PM, Lin HY, Hung CM, Lo GH, Hsu YC, Lu IC, Lee CY, Wu TC, Yeh JH, Hsiao P, Li YC, Wang YC, Hsieh KC, Lin CW. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterol 2021;21:220. [PMID: 33990184 DOI: 10.1186/s12876-021-01807-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Lin YT, Jeng LB, Chan WL, Su IJ, Teng CF. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma. Viruses 2021;13:862. [PMID: 34066744 DOI: 10.3390/v13050862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Tang F, Huang G, Lin L, Yin H, Shao L, Xu R, Cui X. Anti-HBV Activities of Polysaccharides from Thais clavigera (Küster) by In Vitro and In Vivo Study. Mar Drugs 2021;19:195. [PMID: 33808126 DOI: 10.3390/md19040195] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Rao S, Hossain T, Mahmoudi T. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis. Cancer Lett 2021;506:35-44. [PMID: 33675983 DOI: 10.1016/j.canlet.2021.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hyun S, Ko O, Kim S, Ventura WR. Sociocultural barriers to hepatitis B health literacy in an immigrant population: a focus group study in Korean Americans. BMC Public Health 2021;21:404. [PMID: 33632203 DOI: 10.1186/s12889-021-10441-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Xue M, Lin X, Lin QX, Pu X, Liu J, Li XF, Hou J, Liu X, Chen R. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk. Int J Cancer 2021;148:2974-81. [PMID: 33554326 DOI: 10.1002/ijc.33505] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Wang Y, Yang Y, Gao H, Ouyang T, Zhang L, Hu J, Hu S, Kan H. Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma. Front Oncol 2020;10:566183. [PMID: 33665158 DOI: 10.3389/fonc.2020.566183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bomgning CLK, Sinda PVK, Ponou BK, Fotio AL, Tsague MK, Tsafack BT, Kühlborn J, Mbuyo-Nguelefack EP, Teponno RB, Opatz T, Tapondjou LA, Nguelefack TB. Hepatoprotective effects of extracts, fractions and compounds from the stem bark of Pentaclethra macrophylla Benth: Evidence from in vitro and in vivo studies. Biomed Pharmacother 2021;136:111242. [PMID: 33486213 DOI: 10.1016/j.biopha.2021.111242] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Chiang RS, Connor AA, Inman BA, Foo WC, Howell DN, Madden JF, Ellis MJ, Rege AS, Harrison MR. Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor. Case Rep Urol 2020;2020:8881841. [PMID: 33425425 DOI: 10.1155/2020/8881841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Okeke E, Mark Davwar P, Mullen B, Duguru M, Agbaji O, Sagay A, Murphy R, Hawkins C. The impact of HIV on hepatocellular cancer survival in Nigeria. Trop Med Int Health 2021;26:335-42. [PMID: 33244817 DOI: 10.1111/tmi.13532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Liu R, Zheng S, Yuan Q, Zhu P, Li B, Lin Q, Shi W, Min Y, Ge Q, Shao Y. The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis. Dis Markers 2020;2020:4565379. [PMID: 33376559 DOI: 10.1155/2020/4565379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Xiao C, Mei F, Ren G, Long L, Chen M, Fang X, Li J, Li K, Tang Y, Huang T, Deng W. Synergistic Effect of MC-LR and C-Terminal Truncated HBx on HepG2 Cells and Their Effects on PP2A Mediated Downstream Target of MAPK Signaling Pathway. Front Genet 2020;11:537785. [PMID: 33193609 DOI: 10.3389/fgene.2020.537785] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Rashidi S, Farhadi L, Ghasemi F, Sheikhesmaeili F, Mohammadi A. The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective? Infect Genet Evol 2020;85:104580. [PMID: 33022425 DOI: 10.1016/j.meegid.2020.104580] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
31 Teng CF, Wu HC, Su IJ, Jeng LB. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma. Viruses 2020;12:E945. [PMID: 32859114 DOI: 10.3390/v12090945] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
32 Vinhaes CL, Cruz LAB, Menezes RC, Carmo TA, Arriaga MB, Queiroz ATL, Barral-Netto M, Andrade BB. Chronic Hepatitis B Infection Is Associated with Increased Molecular Degree of Inflammatory Perturbation in Peripheral Blood. Viruses 2020;12:E864. [PMID: 32784775 DOI: 10.3390/v12080864] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Zhang Y, Huang G, Miao H, Song Z, Zhang X, Fan W, Wang Y, Li J, Chen Y. Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma. Ther Adv Med Oncol 2020;12:1758835920937422. [PMID: 32754228 DOI: 10.1177/1758835920937422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
34 Teng CF, Li TC, Huang HY, Lin JH, Chen WS, Shyu WC, Wu HC, Peng CY, Su IJ, Jeng LB. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence. Viruses 2020;12:E796. [PMID: 32722114 DOI: 10.3390/v12080796] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
35 Dertli R, Asil M, Biyik M, Karakarcayildiz A, Keskin M, Göktepe HM, Kayar Y, Ataseven H. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma? J Gastrointest Cancer 2021;52:666-75. [PMID: 32617832 DOI: 10.1007/s12029-020-00448-2] [Reference Citation Analysis]
36 McIntyre CA, Chou JF, Gonen M, Shia J, Gambarin-Gelwan M, Balachandran VP, Kingham TP, Allen PJ, Drebin JA, Jarnagin WR, D'Angelica MI. Hepatocellular carcinoma in patients with no identifiable risk factors. HPB (Oxford) 2021;23:118-26. [PMID: 32591247 DOI: 10.1016/j.hpb.2020.05.005] [Reference Citation Analysis]
37 Vescovo T, Pagni B, Piacentini M, Fimia GM, Antonioli M. Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development. Front Cell Dev Biol 2020;8:47. [PMID: 32181249 DOI: 10.3389/fcell.2020.00047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
38 Ai J, Ketabchi N, Verdi J, Gheibi N, Khadem Haghighian H, Kavianpour M. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell Int 2019;19:329. [PMID: 31827403 DOI: 10.1186/s12935-019-1038-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
39 Brezgin S, Kostyusheva A, Bayurova E, Gordeychuk I, Isaguliants M, Goptar I, Nikiforova A, Smirnov V, Volchkova E, Glebe D, Kostyushev D, Chulanov V. Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro. Microorganisms 2019;7:E533. [PMID: 31698767 DOI: 10.3390/microorganisms7110533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
40 Jeng KS, Jeng CJ, Jeng WJ, Sheen IS, Li SY, Leu CM, Tsay YG, Chang CF. Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma. Oncol Lett 2019;18:4377-84. [PMID: 31611946 DOI: 10.3892/ol.2019.10826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
41 Serag WM, Mohamed MM, Elsayed BE, Abd-Elhamed SM. Determination of liver fibrosis stages in Egyptian chronic hepatitis B patients by a noninvasive tool. Turk J Med Sci 2019;49:1145-50. [PMID: 31385666 DOI: 10.3906/sag-1812-165] [Reference Citation Analysis]
42 Teng CF, Yu CH, Chang HY, Hsieh WC, Wu TH, Lin JH, Wu HC, Jeng LB, Su IJ. Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model. Sci Rep 2019;9:10338. [PMID: 31316146 DOI: 10.1038/s41598-019-46891-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol 2019; 25(19): 2279-2293 [PMID: 31148900 DOI: 10.3748/wjg.v25.i19.2279] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 65] [Article Influence: 24.7] [Reference Citation Analysis]
44 Hu Z, Chen H, Chen S, Huang Z, Qin S, Zhong J, Qin X, Li S. The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma. Medicine (Baltimore). 2019;98:e14749. [PMID: 30817633 DOI: 10.1097/md.0000000000014749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
45 Rao J, Wu X, Zhou X, Deng R, Ma Y. Vitamin D Receptor Fok I Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients. Hepat Mon 2019;In Press. [DOI: 10.5812/hepatmon.85075] [Reference Citation Analysis]
46 Fatima I, Kanwal S, Mahmood T. Natural Products Mediated Targeting of Virally Infected Cancer. Dose Response 2019;17:1559325818813227. [PMID: 30670935 DOI: 10.1177/1559325818813227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 Wu Y, Ren F, Chai Y, Xue Z, Shen C, Zhang X, Lv Y, Hu L. Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection. Oncol Lett 2019;17:165-74. [PMID: 30655752 DOI: 10.3892/ol.2018.9618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
48 Lee WY, Bachtiar M, Choo CCS, Lee CG. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics. Biol Rev Camb Philos Soc. 2019;94:353-367. [PMID: 30105774 DOI: 10.1111/brv.12457] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
49 Wu D, Liang H, Wang H, Duan C, Yazdani H, Zhou J, Pan Y, Shan B, Su Z, Wei J, Cui T, Tai S. Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncol Lett 2018;16:4418-26. [PMID: 30214576 DOI: 10.3892/ol.2018.9178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev 2018;32:868-902. [PMID: 29945886 DOI: 10.1101/gad.314849.118] [Cited by in Crossref: 49] [Cited by in F6Publishing: 60] [Article Influence: 12.3] [Reference Citation Analysis]
51 Karin M. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precis Clin Med. 2018;1:21-28. [PMID: 30687560 DOI: 10.1093/pcmedi/pby005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
52 Hernández-Aquino E, Muriel P. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World J Gastroenterol 2018; 24(16): 1679-1707 [PMID: 29713125 DOI: 10.3748/wjg.v24.i16.1679] [Cited by in CrossRef: 133] [Cited by in F6Publishing: 118] [Article Influence: 33.3] [Reference Citation Analysis]
53 Kachingwe BH, Wang LH, Uang YS, Huang TJ, Lin SJ. Dose-dependent pharmacokinetics and tentative identification of urine metabolites from an isosteviol derivative with anti-hepatitis B activity in rats. Biomed Chromatogr 2018;:e4266. [PMID: 29689637 DOI: 10.1002/bmc.4266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Wang Y, Wang H, Pan S, Hu T, Shen J, Zheng H, Xie S, Xie Y, Lu R, Guo L. Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma. J Cancer 2018;9:1575-81. [PMID: 29760795 DOI: 10.7150/jca.24384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
55 Naimimohasses S, El Sherif O, Ashfaq M, Nolan N, Iqbal M, McKiernan S, Norris S. Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma. Case Rep Gastroenterol 2017;11:797-802. [PMID: 29606938 DOI: 10.1159/000484660] [Reference Citation Analysis]
56 Xianyu J, Feng J, Yang Y, Tang J, Xie G, Fan L. Correlation of oxidative stress in patients with HBV-induced liver disease with HBV genotypes and drug resistance mutations. Clin Biochem. 2018;55:21-27. [PMID: 29596793 DOI: 10.1016/j.clinbiochem.2018.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
57 Kang HJ, Chung DH, Sung CO, Yoo SH, Yu E, Kim N, Lee SH, Song JY, Kim CJ, Choi J. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. Oncotarget 2017;8:27263-76. [PMID: 28460481 DOI: 10.18632/oncotarget.15930] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
58 Kuss-Duerkop SK, Westrich JA, Pyeon D. DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis. Viruses 2018;10:E82. [PMID: 29438328 DOI: 10.3390/v10020082] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
59 Du J, Bai F, Zhao P, Li X, Li X, Gao L, Ma C, Liang X. Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2018;1865:1-11. [DOI: 10.1016/j.bbamcr.2017.09.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
60 Feng J, Yang Y, Wang D, Tang J, Xie G, Fan L. Relationship between oxidative stress in patients with HBV-induced liver disease and HBV genotype/drug-resistant mutation. Frontiers in Laboratory Medicine 2017;1:211-6. [DOI: 10.1016/j.flm.2017.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
61 Zhu C, Zhu H, Song H, Xu L, Li L, Liu F, Liu X. Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3. Lipids Health Dis 2017;16:213. [PMID: 29132372 DOI: 10.1186/s12944-017-0607-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
62 Feustel S, Ayón-Pérez F, Sandoval-Rodriguez A, Rodríguez-Echevarría R, Contreras-Salinas H, Armendáriz-Borunda J, Sánchez-Orozco LV. Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells. J Immunol Res 2017;2017:6063850. [PMID: 29214184 DOI: 10.1155/2017/6063850] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
63 Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. Oncotarget 2017;8:23507-16. [PMID: 28186991 DOI: 10.18632/oncotarget.15183] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
64 Lin X, Chang W, Wang Y, Tian M, Yu Z. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017;93:398-405. [DOI: 10.1016/j.biopha.2017.06.075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
65 Rui S, Yan J, Zhang H, Wang Z, Zhou W. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy. Medicine (Baltimore) 2017;96:e7608. [PMID: 28746212 DOI: 10.1097/MD.0000000000007608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Link T, Iwakuma T. Roles of p53 in extrinsic factor-induced liver carcinogenesis. Hepatoma Res 2017;3:95-104. [PMID: 30123836 DOI: 10.20517/2394-5079.2017.07] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
67 Liu Y, Qi X, Zeng Z, Wang L, Wang J, Zhang T, Xu Q, Shen C, Zhou G, Yang S, Chen X, Lu F. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Sci Rep 2017;7:2796. [PMID: 28584302 DOI: 10.1038/s41598-017-03070-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
68 He Z, Yu Y, Nong Y, Du L, Liu C, Cao Y, Bai L, Tang H. Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein. Oncol Lett 2017;14:1323-32. [PMID: 28789347 DOI: 10.3892/ol.2017.6296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
69 Hoseini SS, Cheung NV. Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies. Cancer Lett. 2017;399:44-52. [PMID: 28428075 DOI: 10.1016/j.canlet.2017.04.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
70 Li H, Sheng C, Wang S, Yang L, Liang Y, Huang Y, Liu H, Li P, Yang C, Yang X. Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9. Front Cell Infect Microbiol. 2017;7:91. [PMID: 28382278 DOI: 10.3389/fcimb.2017.00091] [Cited by in Crossref: 46] [Cited by in F6Publishing: 64] [Article Influence: 9.2] [Reference Citation Analysis]
71 Zhang S, Gao S, Zhao M, Liu Y, Bu Y, Jiang Q, Zhao Q, Ye L, Zhang X. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Cancer Lett. 2017;392:94-104. [PMID: 28192212 DOI: 10.1016/j.canlet.2017.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
72 Lin Y, Liu J, Huang Y, Liu D, Zhang G, Kan H. microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7. Transl Oncol 2017;10:211-20. [PMID: 28189067 DOI: 10.1016/j.tranon.2017.01.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
73 Wang M, Xi D, Ning Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 2017;11:171-180. [PMID: 28097530 DOI: 10.1007/s12072-016-9779-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
74 Gong PY, Yuan ZX, Gu J, Tan R, Li JC, Ren Y, Hu S. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds. Molecules 2016;22:E14. [PMID: 28035986 DOI: 10.3390/molecules22010014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Pang Y, Guo W, Wang J, Xu G, Cheng K, Cao G, Wu M, Cheng S, Liu S. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA. Oncotarget 2016;7:8006-18. [PMID: 26769853 DOI: 10.18632/oncotarget.6895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Zhou L, Wen J, Huang Z, Nice EC, Huang C, Zhang H, Li Q. Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis. Proteomics Clin Appl 2017;11. [PMID: 27763721 DOI: 10.1002/prca.201600089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
77 Wang WT, Ye H, Wei PP, Han BW, He B, Chen ZH, Chen YQ. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. J Hematol Oncol. 2016;9:117. [PMID: 27809873 DOI: 10.1186/s13045-016-0348-0] [Cited by in Crossref: 121] [Cited by in F6Publishing: 151] [Article Influence: 20.2] [Reference Citation Analysis]
78 Jung D, Hwang S, Kim K, Hong S, Lee Y, Ahn C, Moon D, Ha T, Song G, Park G, Yu ES, Lee S. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. World J Surg 2017;41:825-34. [DOI: 10.1007/s00268-016-3787-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
79 Deng M, Hou J, Hu J, Wang S, Chen M, Chen L, Ju Y, Li C, Meng S. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma. Cancer Lett. 2016;383:62-72. [PMID: 27693636 DOI: 10.1016/j.canlet.2016.09.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
80 Chávez-López MG, Zúñiga-García V, Pérez-Carreón JI, Avalos-Fuentes A, Escobar Y, Camacho J. Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma. Biologics 2016;10:139-48. [PMID: 27703327 DOI: 10.2147/BTT.S87402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
81 Kerbauy MN, Fernandes CM, Bezerra ED, Lage LA, Siqueira SA, Pereira J. Splenic diffuse red-pulp small B-cell lymphoma associated with hepatitis B virus: a report of two cases. Sao Paulo Med J 2016;134:359-65. [PMID: 27581334 DOI: 10.1590/1516-3180.2016.0035130416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
82 Yamada HY, Kumar G, Zhang Y, Rubin E, Lightfoot S, Dai W, Rao CV. Systemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lung. Oncogenesis 2016;5:e256. [PMID: 27526110 DOI: 10.1038/oncsis.2016.56] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
83 Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Curr Opin Virol 2016;20:1-10. [PMID: 27504999 DOI: 10.1016/j.coviro.2016.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
84 Zhang Y, Fan W, Zhu K, Lu L, Fu S, Huang J, Wang Y, Yang J, Huang Y, Yao W, Li J. Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response. Oncotarget 2015;6:24550-9. [PMID: 26093084 DOI: 10.18632/oncotarget.4076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
85 Zhang Y, Liu H, Yi R, Yan T, He Y, Zhao Y, Liu J. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression. J Exp Clin Cancer Res. 2016;35:87. [PMID: 27255760 DOI: 10.1186/s13046-016-0366-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
86 Chen S, Chen H, Gao S, Qiu S, Zhou H, Yu M, Tu J. Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma. Hepatol Res. 2017;47:312-320. [PMID: 27152955 DOI: 10.1111/hepr.12739] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
87 Li L, Hong HH, Chen SP, Ma CQ, Liu HY, Yao YC. Activation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cells. World J Gastroenterol 2016; 22(17): 4345-4353 [PMID: 27158203 DOI: 10.3748/wjg.v22.i17.4345] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
88 Yu G, Chen X, Chen S, Ye W, Hou K, Liang M. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. J Transl Med. 2016;14:122. [PMID: 27150195 DOI: 10.1186/s12967-016-0888-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
89 Minuk GY, Baruch Y. Hepatitis B viral infection of hepatic progenitor cells. Resolving unresolved questions? Med Hypotheses 2016;91:24-7. [PMID: 27142136 DOI: 10.1016/j.mehy.2016.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Graham K, Murphy JI, Dhoot GK. SULF1/SULF2 reactivation during liver damage and tumour growth. Histochem Cell Biol 2016;146:85-97. [PMID: 27013228 DOI: 10.1007/s00418-016-1425-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
91 Wu Y, Zhang X, Liu Y, Lu F, Chen X. Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma. Int J Mol Sci 2016;17:E153. [PMID: 26821013 DOI: 10.3390/ijms17020153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
92 Villain P, Gonzalez P, Almonte M, Franceschi S, Dillner J, Anttila A, Park JY, De Vuyst H, Herrero R. European Code against Cancer 4th Edition: Infections and Cancer. Cancer Epidemiology 2015;39:S120-38. [DOI: 10.1016/j.canep.2015.10.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
93 Chiu AP, Tschida BR, Lo LH, Moriarity BS, Rowlands DK, Largaespada DA, Keng VW. Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12157-12170 [PMID: 26576100 DOI: 10.3748/wjg.v21.i42.12157] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ma Y, Wang X, Tang N. Downregulation of mPGES-1 Expression via EGR1 Plays an Important Role in Inhibition of Caffeine on PGE2 Synthesis of HBx(+) Hepatocytes. Mediators Inflamm 2015;2015:372750. [PMID: 26538827 DOI: 10.1155/2015/372750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
95 Bak Y, Shin HJ, Bak Is, Yoon DY, Yu DY. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway. Biochem Biophys Res Commun 2015;466:676-81. [PMID: 26392315 DOI: 10.1016/j.bbrc.2015.09.082] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
96 Baran B. Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma. World J Hepatol 2015; 7(13): 1742-1754 [PMID: 26167247 DOI: 10.4254/wjh.v7.i13.1742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
97 Gish RG, Given BD, Lai CL, Locarnini SA, Lau JY, Lewis DL, Schluep T. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antiviral Res 2015;121:47-58. [PMID: 26092643 DOI: 10.1016/j.antiviral.2015.06.008] [Cited by in Crossref: 151] [Cited by in F6Publishing: 161] [Article Influence: 21.6] [Reference Citation Analysis]
98 Shin JH, Kim CJ, Jeon EJ, Sung CO, Shin HJ, Choi J, Yu E. Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas. J Pathol Transl Med. 2015;49:105-111. [PMID: 25812732 DOI: 10.4132/jptm.2015.01.19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
99 Ress AL, Wagle R, Pichler M. Multi-omics in prognosis of hepatocellular carcinoma. Ann Transl Med 2015;3:2. [PMID: 25705634 DOI: 10.3978/j.issn.2305-5839.2014.12.07] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
100 Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6:4047-4079. [PMID: 25341666 DOI: 10.3390/v6104047] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 10.5] [Reference Citation Analysis]